Compass Therapeutics, Inc.: Form 10-Q for the period ended Dec 31, 2018
Filed with the SEC on Feb 14, 2019 and accepted by EDGAR at Feb 14, 2019, 18:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Operating income | 3 months2018-10-01 to 2018-12-31 | −$9.3k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2018-04-01 to 2018-12-31 | −$24.9k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-10-01 to 2018-12-31 | $875 | us-gaap:InterestExpense |
| Interest expense | 9 months2018-04-01 to 2018-12-31 | $2.2k | us-gaap:InterestExpense |
| Net income | 3 months2018-10-01 to 2018-12-31 | −$10.1k | us-gaap:NetIncomeLoss |
| Net income | 9 months2018-04-01 to 2018-12-31 | −$27.2k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-10-01 to 2018-12-31 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2018-04-01 to 2018-12-31 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2018-04-01 to 2018-12-31 | −$22.9k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2018-12-31 | $4.7k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-12-31 | $4.7k | us-gaap:AssetsCurrent |
| Total assets | At period end2018-12-31 | $4.7k | us-gaap:Assets |
| Current liabilities | At period end2018-12-31 | $66.4k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-12-31 | $66.4k | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-12-31 | −$61.7k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-19-002496. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.